keyword
https://read.qxmd.com/read/38628356/case-series-of-retinal-vein-occlusions-showing-early-recovery-using-oral-l-methylfolate
#1
Steven Baker, Dylan Baker, Robert Baker, Craig J Brown
This case series describes the aggregate rate of recovery in five consecutive subjects (six eyes) with retinal vein occlusion (RVO) who received l-methylfolate and other vitamins via Ocufolin® , a medical food. Subjects were followed for 10-33 months by a single ophthalmologist. Ocufolin® was prescribed at the time of diagnosis and subjects remained on the regimen throughout the time of observation. Examinations were performed in an un-masked fashion at 3-month intervals with recording of best corrected visual acuity (BCVA), average retinal nerve fiber layer (ARNFL) and central macular thickness (CMT), and fundus (examination of the retina, macula, optic nerve, and vessels) photography...
2024: Therapeutic Advances in Ophthalmology
https://read.qxmd.com/read/38576143/drugs-for-bipolar-disorder
#2
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38528721/effect-of-l-methylfolate-supplementation-on-sleep-for-patients-with-reduced-methylenetetrahydrofolate-reductase-activity
#3
JOURNAL ARTICLE
Alex S Carmon, Russell J Amato, Seema M Patel, Shannon W Finks
INTRODUCTION: Clinicians have limited options outside controlled substances to address sleep disturbance, which left untreated can negatively affect patient outcomes in cardiovascular health, mental health, immunologic function, and more. For some, genetic factors may influence sleep disturbances. L-methylfolate, the active form of folate, plays a critical role in regulation of monoamine neurotransmitters known to have significant impact on sleep regulation: dopamine, serotonin, norepinephrine...
March 25, 2024: Journal of Dietary Supplements
https://read.qxmd.com/read/38133585/drugs-for-depressionr
#4
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 11, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38056998/the-effects-of-folinic-acid-and-l-methylfolate-supplementation-on-serum-total-homocysteine-levels-in-healthy-adults
#5
JOURNAL ARTICLE
Elias E Mazokopakis, Maria G Papadomanolaki, John A Papadakis
BACKGROUND - AIM: Hyperhomocysteinemia is recognized as a risk factor for several diseases and conditions. The aim of this study was to investigate and compare the efficacy of two total homocysteine (tHcy)-lowering treatments including folinic acid or l-methylfolate in healthy Greek adults. METHODS: Two hundred and seventy-two healthy Greek adults (143 men, 129 women; mean age±SD: 43.0 ± 15.3 years), with serum tHcy levels ≥10 μmol/L received randomized folinic acid ("Folinic acid Group") or l-methylfolate ("l-methylfolate Group") orally for three months...
December 2023: Clinical Nutrition ESPEN
https://read.qxmd.com/read/38035146/safety-of-monosodium-salt-of-l-5-methyltetrahydrofolic-acid-as-a-novel-food-pursuant-to-regulation-eu-2015-2283-and-the-bioavailability-of-folate-from-this-source-in-the-context-of-directive-2002-46-ec-regulation-eu-no-609-2013-and-regulation-ec-no-1925-2006
#6
JOURNAL ARTICLE
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch-Ernst, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Margarita Aguilera-Gómez, Francesco Cubadda, Thomas Frenzel, Marina Heinonen, Miguel Prieto Maradona, Rosangela Marchelli, Monika Neuhäuser-Berthold, Morten Poulsen, Josef Rudolf Schlatter, Alexandros Siskos, Henk van Loveren, Leonard Matijević, Helle Katrine Knutsen
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on monosodium salt of l-5-methyltetrahydrofolic acid (5-MTHF) as a novel food (NF) pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of folate from this source in the context of Directive 2002/46/EC, Regulation (EU) No 609/2013 and Regulation (EC) No 1925/2006. The NF is produced by chemical synthesis and consists of at least 95% (w/w) of 5-MTHF and 4%-5% (w/w) of sodium...
November 2023: EFSA journal
https://read.qxmd.com/read/37810545/homocysteine-reduction-for-stroke-prevention-regarding-the-recent-aha-asa-2021-prevention-of-stroke-in-patients-with-stroke-and-transient-ischemic-attack
#7
JOURNAL ARTICLE
Craig Brown, Jianhua Wang, Hong Jiang, Merrill F Elias
Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reduction. Homocysteine reduction was not included in the recommendations. The reduction of homocysteine with low doses of folic acid has been shown to reduce ischemic stroke and all stroke. This has been obscured by studies using high doses of folic acid and cyanocobalamin in patients with renal failure and Methylenetetrahydrofolate reductase (MTHFR) polymorphisms...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37686891/folate-and-its-significance-in-depressive-disorders-and-suicidality-a-comprehensive-narrative-review
#8
REVIEW
Timur Liwinski, Undine E Lang
Depressive disorders pose significant challenges to global public health, necessitating effective prevention and management strategies. Notably, the occurrence of suicide frequently coincides with depressive episodes. Suicide is as a paramount global health concern that demands efficacious preventive strategies. Current psychiatric approaches heavily rely on pharmacological interventions but have had limited success in addressing the global burden of mental health issues. Suboptimal nutrition, with its impact on the neuroendocrine system, has been implicated in the underlying pathology of depressive disorders...
September 4, 2023: Nutrients
https://read.qxmd.com/read/37565253/methyl-donor-supplementation-reduces-phospho-tau-fyn-and-demethylated-pp2a-levels-and-mitigates-learning-and-motor-deficits-in-a-mouse-model-of-tauopathy
#9
JOURNAL ARTICLE
Annika van Hummel, Goce Taleski, Jean-Marie Sontag, Astrid Feentje Feiten, Yazi D Ke, Lars M Ittner, Estelle Sontag
BACKGROUND: Reduced folate status and elevated levels of circulating homocysteine are modifiable risk factors for cognitive decline and dementia. Disturbances in one-carbon metabolism are associated with the pathological accumulation of phosphorylated tau, a hallmark feature of prevalent dementia, including Alzheimer's disease and subgroups of frontotemporal dementia. METHODS: Here, using transgenic TAU58/2 mouse models of human tauopathy, we tested whether dietary supplementation with L-methylfolate (the active folate form), choline and betaine can reduce tau phosphorylation and associated behavioural phenotypes...
August 11, 2023: Neuropathology and Applied Neurobiology
https://read.qxmd.com/read/37324128/diet-and-ideal-food-pyramid-to-prevent-or-support-the-treatment-of-diabetic-retinopathy-age-related-macular-degeneration-and-cataracts
#10
Mariangela Rondanelli, Clara Gasparri, Antonella Riva, Giovanna Petrangolini, Gaetan Claude Barrile, Alessandro Cavioni, Claudia Razza, Alice Tartara, Simone Perna
Many eye diseases, such as diabetic retinopathy (DR), age-related macular degeneration (AMD), and cataracts are preventable and treatable with lifestyle. The objective of this review is to assess the most recent research on the ideal dietary approach to prevent or support the treatment of DR, AMD, and cataracts, as well as to construct a food pyramid that makes it simple for people who are at risk of developing these pathologies to decide what to eat. The food pyramid presented here proposes what should be consumed every day: 3 portions of low glycemic index (GI) grains (for fiber and zinc content), 5 portions (each portion: ≥200 g/day) of fruits and vegetables (spinach, broccoli, zucchini cooked, green leafy vegetables, orange, kiwi, grapefruit for folic acid, vitamin C, and lutein/zeaxanthin content, at least ≥42 μg/day, are to be preferred), extra virgin olive (EVO) oil (almost 20 mg/day for vitamin E and polyphenols content), nuts or oil seeds (20-30 g/day, for zinc content, at least ≥15...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37192264/a-review-of-l-methylfolate-as-adjunctive-therapy-in-the-treatment-of-major-depressive-disorder
#11
REVIEW
Vladimir Maletic, Richard Shelton, Valerie Holmes
Objective: To examine the potential of using l-methylfolate (LMF) as an adjunctive therapy for major depressive disorder (MDD) and assess its role in filling current treatment gaps for patients who are overweight/obese and have chronic inflammation. Data Sources: The PubMed database was searched using the key words l-methylfolate, adjunctive , and depression to identify studies published from January 2000 to April 2021. Study Selection: Identified studies included 2 randomized controlled trials (RCTs), an open-label extension of these RCTs, and a real-world prospective study...
May 9, 2023: Primary Care Companion to CNS Disorders
https://read.qxmd.com/read/37088147/l-methylfolate-in-diabetic-peripheral-neuropathy-a-narrative-review
#12
REVIEW
Elena A Christofides, Virginia Valentine
OBJECTIVE: One of the most frequently occurring complications of diabetes mellitus is peripheral neuropathy. Despite the painful symptoms associated with diabetic peripheral neuropathy (DPN), the current treatment landscape focuses on managing symptoms without addressing the underlying causes of DPN. This narrative review describes the mechanistic effects and clinical trial data supporting the use of L-methylfolate calcium (LMF), the bioactive form of folate, which is available in the United States as a prescription medical food that also contains other B vitamins for the dietary management of DPN...
August 2023: Endocrine Practice
https://read.qxmd.com/read/37077224/effects-of-methylenetetrahydrofolate-reductase-mthfr-polymorphisms-on-retinal-tissue-perfusion-in-mild-diabetic-retinopathy-patients-receiving-the-medical-food-ocufolin-%C3%A2
#13
JOURNAL ARTICLE
Hong Jiang, Zhiping Liu, Justin H Townsend, Jianhua Wang
PURPOSE: We evaluate the effects of methylenetetrahydrofolate reductase ( MTHFR) polymorphisms on retinal tissue perfusion in patients with mild diabetic retinopathy (DR + PM) taking the medical food, Ocufolin® , for 6 months. METHODS: Prospective, case-controlled study. Eight early diabetic retinopathy patients with common reduced function MTHFR polymorphisms (DR+PM) and 15 normal controls (NC) were recruited. MTHFR polymorphisms were subtyped as normal, C677T , or A1298C ...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/36904166/brain-uptake-of-folate-forms-in-the-presence-of-folate-receptor-alpha-antibodies-in-young-rats-folate-and-antibody-distribution
#14
JOURNAL ARTICLE
Natasha Bobrowski-Khoury, Jeffrey M Sequeira, Edward V Quadros
In a rat model, following exposure to rat folate receptor alpha antibodies (FRαAb) during gestation, FRαAb accumulates in the placenta and the fetus and blocks folate transport to the fetal brain and produces behavioral deficits in the offspring. These deficits could be prevented with folinic acid. Therefore, we sought to evaluate folate transport to the brain in young rat pups and determine what effect FRαAb has on this process, to better understand the folate receptor autoimmune disorder associated with cerebral folate deficiency (CFD) in autism spectrum disorders (ASD)...
February 25, 2023: Nutrients
https://read.qxmd.com/read/36883502/safety-and-efficacy-of-the-complex-deprilium%C3%A2-in-reducing-subclinical-symptoms-of-depression-in-patients-with-chronic-non-communicable-diseases-double-blind-randomized-controlled-study
#15
JOURNAL ARTICLE
Оleg S Chaban, Olena O Khaustova, Dmytro O Assonov, Lesia V Sak
OBJECTIVE: The aim: To evaluate the effectiveness of the use of the Deprilium® complex for the relief of subclinical symptoms of depression in patients with NCD. PATIENTS AND METHODS: Materials and methods: There were 140 patients involved in the study. To assess the subclinical symptoms, the Hamilton Depression Rating Scale (HAM-D) was used. In order to obtain additional information about the patient's condition, the Somatic Symptom Scale SSS-8 and the Quality of Life Scale (QOLS) were used...
2023: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/36519215/medical-foods-for-lowering-homocysteine-in-hypertensive-patients
#16
JOURNAL ARTICLE
Merrill F Elias, Craig J Brown
No abstract text is available yet for this article.
December 14, 2022: Journal of Clinical Hypertension
https://read.qxmd.com/read/36034319/conversion-of-calcium-l-methylfolate-and-6s-5-methyltetrahydrofolic-acid-glucosamine-salt-into-dietary-folate-equivalents
#17
JOURNAL ARTICLE
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch-Ernst, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Peláez, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Francesco Cubadda, José Cortiñas Abrahantes, Céline Dumas, Valeria Ercolano, Ariane Titz, Kristina Pentieva
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion on the conversion of calcium-l-methylfolate and ( 6S )-5-methyltetrahydrofolic acid glucosamine salt (collectively called 5-MTHF hereafter) into dietary folate equivalents (DFE). Following a systematic review, the conclusions of the opinion are based on one intervention study in adults for intakes < 400 μg/day and three intervention studies in adults for intakes ≥ 400 μg/day...
August 2022: EFSA journal
https://read.qxmd.com/read/35753502/a-retrospective-examination-of-adjunctive-l-methylfolate-in-children-and-adolescents-with-unipolar-depression
#18
JOURNAL ARTICLE
Emily A Bopp, Ethan A Poweleit, Marley O Cox, Jenni E Farrow, Jeffrey R Strawn, Luis R Patino Duran, Cynthia A Prows, Melissa P DelBello, Laura B Ramsey
BACKGROUND: Adjunctive l-methylfolate is commonly prescribed for children and adolescents with treatment-resistant mood disorders; however, the relationship between l-methylfolate augmentation across methylenetetrahydrofolate reductase (MTHFR) genotypes in youths with depressive symptoms is unclear. METHODS: We retrospectively examined the electronic health records of patients (N = 412) with depressive symptoms associated with unipolar depressive disorders and their MTHFR C677T genotypes from 2013 to 2019...
September 1, 2022: Journal of Affective Disorders
https://read.qxmd.com/read/35721218/synergic-action-of-l-acetylcarnitine-and-l-methylfolate-in-mouse-models-of-stress-related-disorders-and-human-ipsc-derived-dopaminergic-neurons
#19
JOURNAL ARTICLE
Rosamaria Orlando, Roxana Paula Ginerete, Laura Cavalleri, Vincenza Aliperti, Tiziana Imbriglio, Giuseppe Battaglia, Anna Rita Zuena, Ferdinando Nicoletti, Emilio Merlo Pich, Ginetta Collo
The epigenetic agents, L-acetylcarnitine (LAC) and L-methylfolate (MF) are putative candidates as add-on drugs in depression. We evaluated the effect of a combined treatment with LAC and MF in two different paradigms of chronic stress in mice and in human inducible pluripotent stem cells (hiPSCs) differentiated into dopaminergic neurons. Two groups of mice were exposed to chronic unpredictable stress (CUS) for 28 days or chronic restraint stress (CRS) for 21 day, and LAC (30 or 100 mg/kg) and/or MF (0.75 or 3 mg/kg) were administered i...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/35607436/improved-retinal-microcirculation-in-mild-diabetic-retinopathy-patients-carrying-mthfr-polymorphisms-who-received-the-medical-food-ocufolin-%C3%A2
#20
JOURNAL ARTICLE
Zhiping Liu, Hong Jiang, Justin H Townsend, Jianhua Wang
Purpose: To evaluate the effects of Ocufolin® on retinal microcirculation in patients with mild diabetic retinopathy carrying MTHFR polymorphisms. Methods: In a prospective, case-controlled study, eight patients with mild diabetic retinopathy and MTHFR polymorphisms and 15 normal controls (NC) were recruited. MTHFR polymorphisms were subtyped as normal, C677T, or A1298C. Best-corrected visual acuity (BCVA) was evaluated. Retinal blood flow velocity (BFV) was measured using Retinal Function Imager...
2022: Clinical Ophthalmology
keyword
keyword
71445
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.